Picard Medical (PMI) Raw Materials (2024 - 2026)

Picard Medical has reported Raw Materials for 3 years, with the latest figure at $6.0 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials changed N/A year-over-year to $6.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (changed N/A YoY), and the FY2025 full-year result was $6.1 million, down 3.07% from the prior year.
• Raw Materials for Q1 2026 stood at $6.0 million, down from $6.1 million in the prior quarter.
• The five-year high for Raw Materials was $6.9 million in Q2 2025, with the low at $5.9 million in Q3 2025.
• Historically, Raw Materials has averaged $6.3 million across 3 years, with a median of $6.1 million in 2025.
• The largest YoY upside for Raw Materials was 3.07% in 2025 against a maximum downside of 3.07% in 2025.
• Picard Medical's Raw Materials stood at $6.3 million in 2024, then retreated by 3.07% to $6.1 million in 2025, then dropped by 2.01% to $6.0 million in 2026.
• The last three Raw Materials figures came in at $6.0 million (Q1 2026), $6.1 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.